TransMedics (TMDX) Depreciation & Amortization (CF) (2018 - 2026)

TransMedics' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $11.9 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 93.32% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $32.8 million (up 53.3% YoY), while the FY2025 annual figure was $27.2 million, up 37.59% from the prior year.
• Depreciation & Amortization (CF) was $11.9 million for Q1 2026 at TransMedics, up from $7.5 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $11.9 million in Q1 2026 to a low of $507000.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $4.1 million across 5 years, with a median of $4.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) gained 13.93% in 2022, then surged 230.92% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.3 million in 2022, then jumped by 180.54% to $3.6 million in 2023, then soared by 57.56% to $5.7 million in 2024, then soared by 31.48% to $7.5 million in 2025, then surged by 58.86% to $11.9 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $11.9 million (Q1 2026), $7.5 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.